Loading...
XFRA
BZ7A
Market cap3.76bUSD
Apr 08, Last price  
4.26EUR
1D
-4.05%
1Q
-21.11%
Name

Bumrungrad Hospital PCL

Chart & Performance

D1W1MN
P/E
16.67
P/S
5.04
EPS
9.78
Div Yield, %
3.12%
Shrs. gr., 5y
—
Rev. gr., 5y
6.84%
Revenues
25.72b
+1.35%
6,806,775,1187,895,517,6509,413,122,5598,881,828,8179,337,855,78010,068,958,69111,014,830,03812,982,543,56814,345,985,94915,629,691,66117,660,405,90017,914,672,82318,346,237,77818,325,961,83218,474,311,76412,362,100,37012,460,420,94220,720,563,65525,376,158,56025,717,577,317
Net income
7.77b
+10.97%
1,052,739,2791,095,702,1001,605,462,2011,191,046,6101,245,648,4401,258,494,6821,588,031,7062,666,731,3462,520,782,2692,730,296,1493,435,833,6133,626,173,9333,943,889,2074,151,885,6843,747,729,2951,204,137,5721,215,678,2264,938,221,8507,006,450,9797,774,725,876
CFO
8.67b
+22.23%
1,512,742,8151,137,023,1021,340,654,7161,762,404,2931,707,407,5831,649,259,1841,878,740,8153,024,551,7043,274,259,2393,890,303,1063,987,408,2835,173,643,8835,243,379,0354,733,929,0074,897,346,4092,260,525,4683,556,157,9726,212,622,2817,094,364,4558,671,238,698
Dividend
Aug 23, 20240.05254 EUR/sh
Earnings
Apr 23, 2025

Profile

Bumrungrad Hospital Public Company Limited owns and operates healthcare-related entities in Thailand and internationally. The company offers diagnostic, therapeutic, and intensive care facilities in a medical center. Its outpatient clinics/centers include allergy, arrhythmia, behavioral health, breastfeeding, breast care, children, dental, diabetes, diagnostic, dialysis, digestive disease, emergency, eye, fertility and IVF, health screening, hearing and balance, heart valve, cancer, hyperbaric oxygen therapy, hypertension, joint replacement, liver, memory, men, nephrology, neuroscience, new life healthy aging, orthopedic, Parkinson's disease and movement disorders, perinatal, physical therapy and rehabilitation, plastic surgery, pulmonary, refractive surgery, robotic scoliosis and surgery, skin, sleep lab, spine, sports medicine and lifestyle, surgical, travel medicine, urology, vitalife, and women's, as well as ear, nose, and throat centers. In addition, the company is involved in the real estate assets holding activities; provision of clinical research services; distribution of pharmaceutical and medical goods in specialized stores; operation of personnel development and training center for healthcare services; and patient referral service business. It operates 580 beds and approximately 56 clinics/centers. The company was founded in 1980 and is headquartered in Bangkok, Thailand.
URL
https://www.bumrungrad.com
IPO date
Dec 15, 1989
Employees
Domiciled in
TH
Incorporated in
TH

Valuation

Title
THB in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
25,717,577
1.35%
25,376,159
22.47%
20,720,564
66.29%
Cost of revenue
16,674,380
17,074,978
14,897,204
Unusual Expense (Income)
NOPBT
9,043,197
8,301,181
5,823,359
NOPBT Margin
35.16%
32.71%
28.10%
Operating Taxes
1,603,990
1,582,524
1,072,193
Tax Rate
17.74%
19.06%
18.41%
NOPAT
7,439,207
6,718,657
4,751,166
Net income
7,774,726
10.97%
7,006,451
41.88%
4,938,222
306.21%
Dividends
(4,101,253)
(2,938,460)
(2,542,653)
Dividend yield
2.37%
1.53%
1.38%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
37,089
16,960
23,579
Long-term debt
217,519
141,107
78,838
Deferred revenue
2
Other long-term liabilities
920,131
853,653
797,198
Net debt
(14,002,633)
(10,672,044)
(8,175,455)
Cash flow
Cash from operating activities
8,671,239
7,094,364
6,212,622
CAPEX
(1,216,435)
(1,572,190)
(1,220,606)
Cash from investing activities
(4,984,873)
(2,428,594)
(3,222,521)
Cash from financing activities
(4,224,199)
(3,050,793)
(2,656,112)
FCF
7,288,407
4,542,473
4,582,958
Balance
Cash
12,113,425
10,745,479
8,276,163
Long term investments
2,143,816
84,632
1,708
Excess cash
12,971,362
9,561,303
7,241,843
Stockholders' equity
27,031,077
23,327,935
19,235,464
Invested Capital
15,889,144
15,481,283
13,007,283
ROIC
47.43%
47.17%
36.32%
ROCE
31.33%
33.15%
28.76%
EV
Common stock shares outstanding
867,415
867,415
867,415
Price
199.50
-10.14%
222.00
4.72%
212.00
50.35%
Market cap
173,049,292
-10.14%
192,566,130
4.72%
183,891,980
50.35%
EV
159,360,761
182,191,627
176,017,229
EBITDA
10,120,433
9,397,949
6,940,234
EV/EBITDA
15.75
19.39
25.36
Interest
8,335
2,394
3,547
Interest/NOPBT
0.09%
0.03%
0.06%